Because mTORC2 activity is often elevated in cancer cells and directs metabolic reprogramming [40], [41], an intriguing possibility is that oncogenic Rit-mediated mTORC2 signaling results in the activation of pro-survival pathways. This evidence concerns the gene RIT1 and cancer.